Pharmaceuticals,
Год журнала:
2025,
Номер
18(2), С. 195 - 195
Опубликована: Янв. 31, 2025
Drugs
administered
by
means
of
extravascular
routes
drug
administration
must
be
absorbed
into
the
systemic
circulation,
which
involves
movement
molecules
across
biological
barriers
such
as
epithelial
cells
that
cover
mucosal
surfaces
or
stratum
corneum
covers
skin.
Some
drugs
exhibit
poor
permeation
membranes
may
experience
excessive
degradation
during
first-pass
metabolism,
tends
to
limit
their
bioavailability.
Various
strategies
have
been
used
improve
Absorption
enhancement
include
co-administration
chemical
enhancers,
enzymes,
and/or
efflux
transporter
inhibitors,
changes,
and
specialized
dosage
form
designs.
Models
with
physiological
relevance
are
needed
evaluate
efficacy
absorption
techniques.
in
vitro
cell
culture
models
ex
vivo
tissue
explored
quantify
effectiveness
strategies.
This
review
deliberates
on
use
for
evaluation
selected
including
nasal,
oromucosal,
pulmonary,
oral,
rectal,
transdermal
administration.
ACS Sensors,
Год журнала:
2024,
Номер
9(7), С. 3466 - 3488
Опубликована: Июль 11, 2024
Organ-on-a-Chip
(OOC)
technology,
which
emulates
the
physiological
environment
and
functionality
of
human
organs
on
a
microfluidic
chip,
is
undergoing
significant
technological
advancements.
Despite
its
rapid
evolution,
this
technology
also
facing
notable
challenges,
such
as
lack
vascularization,
development
multiorgan-on-a-chip
systems,
replication
body
single
chip.
The
progress
has
played
crucial
role
in
steering
OOC
toward
mimicking
microenvironment,
including
microenvironment
replication,
multiorgan
microphysiological
systems.
Additionally,
advancements
detection,
analysis,
organoid
imaging
technologies
have
enhanced
efficiency
Organs-on-Chips
(OOCs).
In
particular,
integration
artificial
intelligence
revolutionized
imaging,
significantly
enhancing
high-throughput
drug
screening.
Consequently,
review
covers
research
Human-on-a-chip,
sensors
OOCs,
latest
applications
biomedical
field.
Bioengineering,
Год журнала:
2024,
Номер
11(7), С. 664 - 664
Опубликована: Июнь 28, 2024
Recent
advancements
in
3D
bioprinting
and
microfluidic
lab-on-chip
systems
offer
promising
solutions
to
the
limitations
of
traditional
animal
models
biomedical
research.
Three-dimensional
enables
creation
complex,
patient-specific
tissue
that
mimic
human
physiology
more
accurately
than
models.
These
bioprinted
tissues,
when
integrated
with
systems,
can
replicate
dynamic
environment
body,
allowing
for
development
multi-organ
This
integration
facilitates
precise
drug
screening
personalized
therapy
by
simulating
interactions
between
different
organ
systems.
Such
innovations
not
only
improve
predictive
accuracy
but
also
address
ethical
concerns
associated
testing,
aligning
three
Rs
principle.
Future
directions
include
enhancing
resolution,
developing
advanced
bioinks,
incorporating
AI
optimized
system
design.
technologies
hold
potential
revolutionize
development,
regenerative
medicine,
disease
modeling,
leading
effective,
personalized,
humane
treatments.
Biotechnology and Bioengineering,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 8, 2025
ABSTRACT
The
small
intestine
is
an
area
of
the
digestive
system
difficult
to
access
using
current
medical
procedures,
which
prevents
studies
on
interactions
between
food,
drugs,
intestinal
epithelium,
and
resident
microbiota.
Therefore,
there
a
need
develop
novel
microfluidic
models
that
mimic
biological
mechanical
environments.
These
can
be
used
for
drug
discovery
disease
modeling
have
potential
reduce
reliance
animal
models.
goal
this
study
was
chip
with
both
enterocyte
(Caco‐2)
goblet
(HT29‐MTX)
cells
cocultured
Lacticaseibacillus
rhamnosus
biofilms,
one
several
genera
present
in
L.
introduced
following
establishment
epithelial
barrier.
shear
stress
within
device
kept
lower
physiological
range
(0.3
mPa)
enable
biofilm
development
over
vitro
epithelium.
barrier
differentiated
after
5
days
dynamic
culture
cell
polarity
permeability
similar
human
intestine.
presence
biofilms
did
not
alter
barrier's
conditions.
Under
fluid
flow,
complete
model
remained
viable
functional
more
than
days,
while
static
only
1
day.
increased
secretion
acidic
neutral
mucins
by
Furthermore,
also
showed
MUC2
production,
dominant
gel‐forming
mucin
This
builds
previous
publications
as
it
establishes
stable
environment
closely
mimics
vivo
conditions
physiology,
food‐intestinal
interactions,
development.
Biosensors and Bioelectronics,
Год журнала:
2024,
Номер
255, С. 116243 - 116243
Опубликована: Март 24, 2024
Fungal
infections
are
a
significant
global
health
problem,
particularly
affecting
individuals
with
weakened
immune
systems.
Moreover,
as
uncontrolled
antibiotic
and
immunosuppressant
use
increases
continuously,
fungal
have
seen
dramatic
increase,
some
strains
developing
resistance.
Traditional
approaches
to
identifying
often
rely
on
morphological
characteristics,
thus
owning
limitations,
such
struggles
in
several
or
distinguishing
between
similar
morphologies.
This
review
explores
the
multifaceted
impact
of
fungi
individuals,
healthcare
providers,
society,
highlighting
often-underestimated
economic
burden
implications
these
infections.
In
light
serious
constraints
traditional
identification
methods,
this
discusses
potential
plasmonic
nanoparticle-based
biosensors
for
infection
identification.
These
can
enable
rapid
precise
pathogen
detection
by
exploiting
readout
approaches,
including
various
spectroscopic
techniques,
colorimetric
electrochemical
assays,
well
lateral-flow
immunoassay
methods.
we
report
remarkable
Lab
Chip
technology
microfluidic
devices,
they
recently
emerged
class
advanced
biosensors.
Finally,
provide
an
overview
smartphone-based
Point-of-Care
devices
associated
technologies
developed
detecting
pathogens.
Lab on a Chip,
Год журнала:
2024,
Номер
24(7), С. 2094 - 2106
Опубликована: Янв. 1, 2024
Organ-on-chip
(OOC)
technology
has
recently
emerged
as
a
powerful
tool
to
mimic
physiological
or
pathophysiological
conditions
through
cell
culture
in
microfluidic
devices.
One
of
its
main
goals
is
bypassing
animal
testing
and
encouraging
more
personalized
medicine.
The
recent
incorporation
hydrogels
3D
scaffolds
into
devices
changed
biomedical
research
since
they
provide
biomimetic
extracellular
matrix
recreate
tissue
architectures.
However,
this
presents
some
drawbacks
such
the
necessity
for
physical
structures
pillars
confine
these
hydrogels,
well
difficulty
reaching
different
shapes
patterns
create
convoluted
gradients
realistic
biological
structures.
In
addition,
can
also
interfere
with
fluid
flow,
altering
local
shear
forces
and,
therefore,
modifying
mechanical
environment
OOC
model.
work,
we
present
methodology
based
on
plasma
surface
treatment
that
allows
building
chambers
abutment-free
capable
producing
precise
stress
distributions.
Therefore,
pillarless
arbitrary
geometries
are
needed
obtain
versatile,
reliable,
experimental
models.
Through
computational
simulation
studies,
changes
demonstrated
designed
fabricated
geometries.
To
prove
versatility
new
technique,
blood-brain
barrier
model
been
recreated,
achieving
an
uninterrupted
endothelial
emulates
part
neurovascular
network
brain.
Finally,
developed
could
avoid
limitations
mentioned
above,
allowing
development
models
complex
adaptable
geometries,
cell-to-cell
contact
if
required,
where
flow
be
controlled.
Stem Cell Research & Therapy,
Год журнала:
2024,
Номер
15(1)
Опубликована: Май 31, 2024
X-linked
juvenile
retinoschisis
(XLRS)
is
an
inherited
disease
caused
by
RS1
gene
mutation,
which
leads
to
retinal
splitting
and
visual
impairment.
The
mechanism
of
RS1-associated
degeneration
not
fully
understood.
Besides,
animal
models
XLRS
have
limitations
in
the
study
XLRS.
Here,
we
used
human
induced
pluripotent
stem
cell
(hiPSC)-derived
organoids
(ROs)
investigate
mechanisms
potential
treatments
for
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 13, 2024
Abstract
The
development
of
personalized
precision
medicine
has
become
a
pivotal
focus
in
modern
healthcare.
Organoids‐on‐a‐Chip
(OoCs),
groundbreaking
fusion
organoid
culture
and
microfluidic
chip
technology,
emerged
as
promising
approach
to
advancing
patient‐specific
treatment
strategies.
In
this
review,
the
diverse
applications
OoCs
are
explored,
particularly
their
role
medicine,
potential
cutting‐edge
technology
is
highlighted.
By
utilizing
patient‐derived
organoids,
offer
pathway
optimize
treatments,
create
precise
disease
models,
investigate
mechanisms,
conduct
drug
screenings,
individualize
therapeutic
emphasis
on
significance
technological
revolutionizing
healthcare
improving
patient
outcomes.
Furthermore,
transformative
future
prospects,
ongoing
advancements
field,
with
genomic
multi‐omics
integration,
ethical
frameworks
discussed.
convergence
these
innovations
can
empower
patients,
redefine
approaches,
shape
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Июль 31, 2024
Abstract
The
female
reproductive
system
comprises
the
internal
and
external
genitalia,
which
communicate
through
intricate
endocrine
pathways.
Besides
secreting
hormones
that
maintain
secondary
sexual
characteristics,
it
also
produces
follicles
offspring.
However,
in
vitro
systems
have
been
very
limited
recapitulating
specific
anatomy
pathophysiology
of
women.
Organ-on-a-chip
technology,
based
on
microfluidics,
can
better
simulate
cellular
microenvironment
vivo,
opening
a
new
field
for
basic
clinical
research
diseases.
This
technology
not
only
reconstruct
organ
structure
but
emulate
function
as
much
possible.
precisely
controlled
fluidic
provided
by
microfluidics
vividly
mimics
complex
hormone
crosstalk
among
various
organs
system,
making
powerful
preclinical
tool
future
pathophysiological
models
system.
Here,
we
review
application
organ-on-a-chip
platforms
systems,
focusing
latest
progress
developing
reproduce
physiological
functions
or
disease
features
tissues,
highlighting
challenges
directions
this
field.